Malaria vaccine shows early promise in clinical trials

Researchers found the vaccine, which is being developed in the US, protected 12 out of 15 patients from the disease, when given in high doses. The method is unusual because it involves injecting live but weakened malaria-causing parasites directly into patients to trigger immunity. via Pocket http://www.bbc.co.uk/news/health-23607612#sa-ns_mchannel=rss&ns_source=PublicRSS20-sa